Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07478432Not ApplicableNot Yet Recruiting

Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery

Role: collaborator

NCT05742373Not ApplicableRecruiting

Role of Fasted Exercise on Improving Cardiometabolic Health

Role: collaborator

NCT03881826Not ApplicableCompleted

Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia

Role: collaborator

NCT04202939Unknown

nutritionDay in Nursing Homes Worldwide: An International Audit and Registry on Nutrition and Outcome

Role: collaborator

NCT02820246Unknown

NutritionDay in Worldwide Hospitals: An International Audit and Registry on Nutrition and Outcome

Role: collaborator

NCT04549961Unknown

123 nutritionDay in Worldwide ICUs: An International Audit and Registry on Nutrition and Outcome.

Role: collaborator

NCT02796430Completed

The ICALIC International Multicentric Study

Role: collaborator

NCT01372176Phase 4Completed

Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial

Role: collaborator

All 8 trials loaded